Literature DB >> 10640643

Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation.

J A Reddy1, P S Low.   

Abstract

Liposomal gene therapy vectors that penetrate cells by endocytosis must escape an endosomal compartment in order to enter the target cell's nucleus. Because such endosomal compartments are generally acidic in nature, pH-sensitive liposomes have been designed that are stable at extracellular pH ( approximately pH 7.4) but fusogenic at endosomal pH values ( approximately pH 5). We report here the use of a novel folate-targeted, pH-sensitive, anionic liposomal vector that mediates the efficient delivery of DNA into folate receptor-bearing cells and discharges the DNA into the cytoplasm. N-Citraconyl-dioleoylphosphatidylethanolamine (C-DOPE), a derivative of dioleylphosphatidylethanolamine (DOPE) that hydrolyzes rapidly at pH 5 to yield DOPE, was synthesized and incorporated with DOPE and folate-polyethyleneglycol-DOPE into liposomes. The resulting liposomes were stable at neutral pH but fusogenic at pH 5. Folate-labeled gene transfer vectors were prepared by compacting plasmid DNA with polylysine at a 1:0.75 (w/w) ratio and complexing the condensed cationic plasmid with the above anionic liposomes. Association of the polylysine-DNA with the liposomes was confirmed by sucrose gradient centrifugation, where migration of the folate-labeled vectors was midway between that of the free liposomes and condensed polylysine-DNA. Transfection of cultured cancer cells with the pH-sensitive liposomal vectors was found to be significantly more efficient than transfection with DOPE-cholesterol hemisuccinate-based vectors, the more commonly used pH-dependent, liposomal transfection formulation. Optimization studies revealed that inclusion of only 3% C-DOPE and 0.1% folate-derivatized DOPE yielded the highest transfection activity. Nearly quantitative competition with free folic acid as well as direct correlation of transfection efficiency with folate receptor density for several different cell lines further documented that vector uptake was mediated by folate receptor endocytosis. Taken together, these data argue that C-DOPE warrants further consideration as a pH sensitive component of lipid-based gene delivery formulations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10640643     DOI: 10.1016/s0168-3659(99)00135-2

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  15 in total

1.  The effects of folate-conjugated gold nanorods in combination with plasmonic photothermal therapy on mouth epidermal carcinoma cells.

Authors:  Alireza Mehdizadeh; Sajjad Pandesh; Ali Shakeri-Zadeh; Seyed Kamran Kamrava; Mojtaba Habib-Agahi; Mohammad Farhadi; Morteza Pishghadam; Amirhossein Ahmadi; Sanam Arami; Yuri Fedutik
Journal:  Lasers Med Sci       Date:  2013-09-07       Impact factor: 3.161

2.  Preparation and characterization of stable pH-sensitive vesicles composed of α-tocopherol hemisuccinate.

Authors:  Huan Xu; Yi-Hui Deng; Kai-Qian Wang; Da-Wei Chen
Journal:  AAPS PharmSciTech       Date:  2012-10-03       Impact factor: 3.246

Review 3.  DNA-based therapeutics and DNA delivery systems: a comprehensive review.

Authors:  Siddhesh D Patil; David G Rhodes; Diane J Burgess
Journal:  AAPS J       Date:  2005-04-08       Impact factor: 4.009

4.  Silencing of the MYCN gene by siRNA delivered by folate receptor-targeted liposomes in LA-N-5 cells.

Authors:  Chen Feng; Tianyou Wang; Ruihong Tang; Jianwen Wang; Hui Long; Xiaoning Gao; Suoqin Tang
Journal:  Pediatr Surg Int       Date:  2010-08-25       Impact factor: 1.827

5.  Enhanced intercellular retention activity of novel pH-sensitive polymeric micelles in wild and multidrug resistant MCF-7 cells.

Authors:  Ghazal Mohajer; Eun Seong Lee; You Han Bae
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.200

Review 6.  Lipid-based nanotherapeutics for siRNA delivery.

Authors:  A Schroeder; C G Levins; C Cortez; R Langer; D G Anderson
Journal:  J Intern Med       Date:  2010-01       Impact factor: 8.989

7.  DNA as therapeutics; an update.

Authors:  P Saraswat; R R Soni; A Bhandari; B P Nagori
Journal:  Indian J Pharm Sci       Date:  2009-09       Impact factor: 0.975

8.  Ultrasound-mediated release of hydrophilic and lipophilic agents from echogenic liposomes.

Authors:  Jonathan A Kopechek; Todd M Abruzzo; Boyu Wang; Stephen M Chrzanowski; Denise A B Smith; Patrick H Kee; Shaoling Huang; Joel H Collier; David D McPherson; Christy K Holland
Journal:  J Ultrasound Med       Date:  2008-11       Impact factor: 2.153

9.  Enhanced transfection efficiency of a systemically delivered tumor-targeting immunolipoplex by inclusion of a pH-sensitive histidylated oligolysine peptide.

Authors:  Wei Yu; Kathleen F Pirollo; Bin Yu; Antonina Rait; Laiman Xiang; Weiqun Huang; Qi Zhou; Gözen Ertem; Esther H Chang
Journal:  Nucleic Acids Res       Date:  2004-03-16       Impact factor: 16.971

Review 10.  NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease.

Authors:  Daniel Martinez-Fong; Michael J Bannon; Louis-Eric Trudeau; Juan A Gonzalez-Barrios; Martha L Arango-Rodriguez; Nancy G Hernandez-Chan; David Reyes-Corona; Juan Armendáriz-Borunda; Ivan Navarro-Quiroga
Journal:  Nanomedicine       Date:  2012-03-07       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.